At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Benzoyl Peroxide +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Benzaknen® 5% Gel in Combination With Dermotivin® Soft Liquid Soap and Non-comedogenic Cetaphil® Dermacontrol Moisturizer SPF30 in the Treatment of Mild-to-moderate Acne Vulgaris
In Brief
A Phase 4 clinical trial evaluating Benzoyl Peroxide, Dermotivin® Soft Liquid cleanser, and 1 other intervention for Acne Vulgaris. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesGermany
CollaboratorsProinnovera GmbH
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartAug 2015
First PostedOct 2015
Primary CompletionJan 2016
TodayJul 2026
First PostedOct 28, 2015
Enrollment StartAug 1, 2015
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.7 years ago
Interventions
Benzoyl Peroxidedrug
Dermotivin® Soft Liquid cleanserother
Cetaphil® Dermacontrol Moisturizer SPF30other